Skip to Main Content

Paper Details

A genetic variant in telomerase reverse transcriptase (TERT) modifies cancer risk in Lynch syndrome patients harbouring pathogenic MSH2 variants.
Sci Rep
6
2021
AA, C, CRC, LS, LS cancer, Lynch syndrome, MLH1, MSH2, MSH2 pathogenic variant, MSH2 variant, MSH2 variants, MSH6, SNP rs2075786, TERT, cancer, cancers, colorectal cancer, intronic variant, patients, rs2075786, rs2075786 SNP, rs2736108, rs7705526, telomerase reverse transcriptase, upstream variant
Author NameAffiliation
Jan LubinskiInternational Hereditary Cancer Center, Pomeranian Medical University
Jan LubinskiInternational Hereditary Cancer Center, Pomeranian Medical University
Rodney J ScottHunter Medical Research Institute
Rodney J ScottSchool of Biomedical Science and Pharmacy, University of Newcastle
Rodney J ScottJohn Hunter Hospital
  • 1 - 5

Datasets

Release 1.2